CN109350685A - A kind of the medicine group principle and its production dosage form of medicine group that treating coronary heart disease and treatment coronary heart disease - Google Patents
A kind of the medicine group principle and its production dosage form of medicine group that treating coronary heart disease and treatment coronary heart disease Download PDFInfo
- Publication number
- CN109350685A CN109350685A CN201811348766.3A CN201811348766A CN109350685A CN 109350685 A CN109350685 A CN 109350685A CN 201811348766 A CN201811348766 A CN 201811348766A CN 109350685 A CN109350685 A CN 109350685A
- Authority
- CN
- China
- Prior art keywords
- grams
- heart disease
- coronary heart
- medicine group
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Marine Sciences & Fisheries (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Western medical treatment coronary heart disease main method is at present: upper bracket puts up a bridge, is aided with promoting circulation of blood stagnation resolvation Western medicine.Feature is temporary solution, does not effect a permanent cure, at high cost easy to recur.Treatment coronary heart disease Chinese medicine group feature of the present invention is: treating both manifestation and root cause of disease, body spleen kidney yang gas is mended, dredges the major cycle of body qi and blood (effecting a permanent cure), thoroughly removes heart aorta acute purulent lymphadenitis, restore heart blood supply channel, to restore heart institute functional (temporary solution).Treatment coronary heart disease medicine group of the present invention is all usual Chinese medicine, and substantially without toxic herb, dose is medium, and compatibility is scientific and reasonable, thus has three advantages: A curative effect speed only needs three secondary Chinese medicines, three to five days time, so that it may thoroughly remove heart aorta acute purulent lymphadenitis；B is at low cost, cures an example coronary heart disease by Chinese medicine current price, only need to less than 100 yuan Chinese medicine costs；C is safe and non-toxic, without side-effects.Through 32 people's clinical verifications, no an example is invalid, effective percentage 100%.
Description
Technical field
The present invention relates to the medicine group principles and its production dosage form of a kind of medicine group for treating coronary heart disease and treatment coronary heart disease.
Background technique
The means of western medical treatment coronary heart disease include that drug therapy, percutaneous coronary intervention (pci) (PCI) i.e. upper bracket are controlled
It treats and Coronary Artery Bypass Grafting (abbreviation off pump coronary artery bypass, CABG).
The purpose of western medicine is to alleviate symptom, reduces anginal breaking-out and myocardial infarction；Delay coronary artery athero-
The development of lesion is hardened, coronary heart disease death is reduced.Percutaneous coronary intervention (pci) (PCI) is percutaneous coronary intracavity forming
Art (PTCA) applies special bag catheter, is sent at coronary stenosis through peripheral arterial (femoral artery or radial artery), fills gas
The expansible narrow lumen of capsule improves blood flow, and places bracket, pre- anti-restenosis in the stenosis expanded.By coronary artery
Road transplantation is alleviated pectoralgia and ischaemic, improves the quality of life of patient, and can be prolonged by the perfusion of recovery myocardial blood flow
The life of long patient.
Treatment with western less effective, when progression of the disease to a certain extent, doctor trained in Western medicine can only just take upper bracket or coronary artery
Put up a bridge treatment, upper bracket or coronary artery bypass grafting treatment have certain risk and spend it is very high, therefore, coronary heart disease extreme influence
People's lives quality also takes life killer by force as the middle-aged and the old.
Coronary heart disease belongs to the thoracic obstruction (pained) of Chinese medicine and/angina pectoris of fainting.Mainly due to worn with age, healthy tendency virtual loss, dirty
Internal organs function damage, yin and yang qi and blood disorder, in addition the shadow that inernal injuries caused by seven emotions, eating and drinking without temperance, cold stimulation, work and rest immoderation etc. are multifactor
It rings, may eventually lead to the formation of coronary heart disease.
It is applicant's understanding that coronary heart disease is mainly that heart aorta phlegm and toxin stasis causes, the heart aorta acute purulent lymphadenitis stasis of blood is cleaned up
Resistance, can treat coronary heart disease.
Summary of the invention
The technical problem to be solved in the present invention is to provide the medicine group principles for the treatment of coronary heart disease.
In order to solve the above technical problems, the present invention provides a kind of medicine group principle for treating coronary heart disease: cleaning heart aorta
Phlegm and toxin stasis.
The present invention also technical problems to be solved, which are to provide, a kind of treats coronary heart disease medicine group, it is desirable that the medicine group can thoroughly remove
Heart aorta acute purulent lymphadenitis.In addition, also providing the production dosage form of the medicine group.
In order to solve the above technical problems, the present invention provides and a kind of treats coronary heart disease medicine group, including following component: dried rehamnnia root 15
Gram, 12 grams of ramulus cinnamomi, 9 grams of red ginseng, 10 grams of root of kirilow rhodiola, 20 grams of ginkgo leaf, 12 grams of Rhizoma Chuanxiong, 15 grams of Radix Salviae Miltiorrhizae, 12 grams of rhizoma acori graminei, Radix Polygalae 10
Gram, 12 grams of Longstamen Onion Bulb, 15 grams of perillaseed, 9 grams of betel nut, 15 grams of oyster, 10 grams of monkshood, 12 grams of cortex cinnamomi, 15 grams of rhizoma atractylodis, 9 grams of cimicifugae foetidae.
The core medicine group of the treatment coronary heart disease medicine group are as follows: 15 grams of Radix Salviae Miltiorrhizae, 12 grams of rhizoma acori graminei, 10 grams of Radix Polygalae, 12 grams of Longstamen Onion Bulb.
Radix Salviae Miltiorrhizae is bitter in taste, tepor；Enter the heart, Liver Channel.With promoting blood circulation, calming heart and tranquilizing mind, relieving restlessness and restlessness, cool blood to disappear carbuncle function
Effect.For chest impediment and cardialgia, stomach duct and abdomen hypochondriac pain, the accumulation of lump in the abdomen lump in the abdomen, hot numbness pain, dysphoria and insomnia.
Rhizoma acori graminei slightly warm in nature, acrid flavour, hardship.Thoughts of returning home warp, stomach meridian.It is main to contain volatile oil.Main component is asarone in volatile oil
And safrole, alpha-ararin, β-asarone, asarabacca brain, acoradiene, cedrene, α-cedrol, cinnaldehydrum, α-deodar
32 kinds of micro constitutents such as alkene, aristolenone, sekishone, Changpujian A, calamus alkali second, eugenol.Can have one's ideas straightened out, slit phlegm, qi-regulating,
Promoting blood circulation, is dried at relieve heat.Belong to awaking drug.Missing, spasmolysis, antibacterial, the anti-rhythm of the heart is reproduced with calm, anticonvulsion, improvement memory to lose
Often, reducing blood lipid, the pharmacological actions such as have one's ideas straightened out.
Radix Polygalae is warm-natured, bitter, pungent.Thoughts of returning home warp, kidney channel, lung channel.Have tranquilize the mind and promote the intelligence, eliminating the phlegm, detumescence, decompression and it is antibacterial, in
Pivot calmness and anticonvulsant action.Belong to the heart-nourishing tranquilizer of sedative subordinate classification.
Longstamen Onion Bulb is warm-natured, acrid flavour, hardship.Thoughts of returning home warp, lung channel, stomach meridian, large intestine channel.It can activate yang and remove abstruction, promoting the circulation of qi promoting.Belong to qi-regulating
Medicine.Pharmacological research its with antiatherosclerosis, anti-platelet aggregation, interference arachidonic acid metabolic, anti-oxidant, antibacterial etc.
Effect.Clinic is chiefly used in treating thoracic obstruction pain.
Radix Salviae Miltiorrhizae, rhizoma acori graminei, Radix Polygalae, Longstamen Onion Bulb, Rhizoma Chuanxiong are the medicine group for changing heart phlegm；Dried rehamnnia root, ramulus cinnamomi can bushing yin, heart-yang, use
In treatment cardiac arrhythmia；Red ginseng, root of kirilow rhodiola, ginkgo leaf are for reinforcing power aroused in interest；Monkshood, cortex cinnamomi, cimicifugae foetidae can tonifying spleen kidney yang, promote complete
Body circulation；Part of the body cavity above the diaphragm housing the heart and lungs dry phlegm-syndrome can drop in perillaseed, betel nut falls Jiao Tanshui；Oyster can resolving sputum, latent yin-yang reinforce the kidney.
Coronary heart disease is mainly that heart aorta phlegm and toxin stasis causes, and cleans up heart aorta phlegm and toxin stasis, can treat
Coronary heart disease.Heart aorta phlegm and toxin stasis is removed by taking Chinese medicine, that is, has fundamentally treated coronary heart disease.
Treatment coronary heart disease Chinese medicine group feature of the present invention is: treating both manifestation and root cause of disease.Body spleen kidney yang gas is mended, body qi and blood is dredged
Major cycle (effects a permanent cure).It thoroughly removes heart aorta acute purulent lymphadenitis, restores heart blood supply channel, to restore that heart institute is functional (to be controlled
Mark).
Coronary heart disease medicine group is treated, is all usual Chinese medicine, substantially without toxic herb, dose is medium, and compatibility is scientific and reasonable, thus
Have three advantages: A curative effect speed only needs three secondary Chinese medicines, three to five days time, so that it may thoroughly remove heart aorta acute purulent lymphadenitis；B cost
It is low, an example coronary heart disease is cured by Chinese medicine current price, it only need to less than 100 yuan Chinese medicine costs；C is safe and non-toxic, without side-effects.Through 32
People's clinical verification, no an example are invalid.Effective percentage 100%.
It includes decoction, pill, powder, granule that treatment coronary heart disease medicine group of the present invention, which can make dosage form,.
Two detailed medical records of clinic are provided below, to further illustrate effect of the invention:
No. 1 patient Zheng * *, male, 63 years old, intend because of " uncomfortable in chest, pectoralgia half a year repeatedly, exacerbation 2 days " within August in 2017 11st " 1, no
Stable angina pectoris；2, coronary atherosclerotic heart disease " is in Bangfu City No.2 People's Hospital's hospitalization, admission number:
1714578.Radial artery row coronary angiography and PCT art on the right side of 14 Nikkei of August in 2017, improve discharge after one piece of bracket of implantation.
Leave hospital after half a year, because uncomfortable in chest, pectoralgia recurrent exerbation removes hospital therapy, doctor suggests undergoing percutaneous coronary interventional therapy again
(PCI), because there is a upper bracket experience, compare resistance, be asking the applicant's diagnosis and treatment, felt the pulse and inquire that state of an illness determination is heart
Aorta phlegm and toxin stasis causes, and writes out a prescription totally three doses, does not have uncomfortable in chest, pectoralgia sense after taking three days, patient is very satisfied.
To currently, having no that coronary artery disease is reaccessed.
Heart result of ultrasonography is shown in that attached drawing 1, the results are shown in attached figure 2 for recent Cardiac ultrasound before patient takes Chinese medicine.Through
Hospital Physical Examination has been not required to re-treatment at present.
No. 2 patient Wu * *, male, 66 years old, for many years, in December, 2016 checked the (heart in People's Hospital No.3, Bengbu City to coronary heart disease
Dirty result of ultrasonography is shown in attached drawing 3).On November 25th, 2017 intends " 1, coronary disease because of " uncomfortable 10 years uncomfortable in chest repeatedly, aggravate half a month "
Disease；2,1 grade of hypertension " is in the hospitalization of the second affiliated hospital of Bengbu Medical College, admission number: 1721434.It is invigorated blood circulation in hospital
Supportive treatment of suiting the medicine to the illness, the symptoms such as stagnation resolvation, coronary dilatation, anti-platelet aggregation, tune rouge, decompression are left hospital after improving.Go out soon after discharge
Now discomfort uncomfortable in chest repeatedly takes orally the control of the drugs such as rosuvastatin calcium tablets and benazepil, after because of uncomfortable in chest, dizzy exacerbation, Bangbu
Undergoing percutaneous coronary interventional therapy (PCI) suggests in third the People's Hospital of city, can treat afterwards because listening classmate to talk about the applicant
Coronary heart disease, be asking the applicant's diagnosis and treatment in June, 2018, felt the pulse at that time: double cun pulses are real, and double rulers are heavy thin.It is thought of as heart master
Artery phlegm and toxin stasis causes, and writes out a prescription totally three doses, and uncomfortable in chest, dizzy disappearance after taking three days, patient voluntarily adheres to taking two doses again.
Hospital is gone to check, index is normal, and diagnosis is completely without undergoing percutaneous coronary interventional therapy (PCI).
To currently, having no that coronary artery disease is reaccessed.
Heart result of ultrasonography is shown in attached drawing 3 before patient takes Chinese medicine.
Detailed description of the invention
Fig. 1: No. 1 patient takes heart result of ultrasonography before medicine group of the present invention.
Fig. 2: No. 1 patient takes Cardiac ultrasound result after medicine group of the present invention.
Fig. 3: No. 2 patients take heart result of ultrasonography before medicine group of the present invention.
Specific embodiment
The present invention can further be well understood below by the embodiment provided.But they are not to of the invention
It limits.
A kind of medicine group cleared up heart aorta phlegm and toxin stasis and then treat coronary heart disease:
15 grams of dried rehamnnia root, 12 grams of ramulus cinnamomi, 9 grams of red ginseng, 10 grams of root of kirilow rhodiola, 20 grams of ginkgo leaf, 12 grams of Rhizoma Chuanxiong, 15 grams of Radix Salviae Miltiorrhizae,
12 grams of rhizoma acori graminei, 10 grams of Radix Polygalae, 12 grams of Longstamen Onion Bulb, 15 grams of perillaseed, 9 grams of betel nut, 15 grams of oyster, 10 grams of monkshood, 12 grams of cortex cinnamomi, rhizoma atractylodis
15 grams, 9 grams of cimicifugae foetidae.
Core medicine group therein are as follows: 15 grams of Radix Salviae Miltiorrhizae, 12 grams of rhizoma acori graminei, 10 grams of Radix Polygalae, 12 grams of Longstamen Onion Bulb.
It includes decoction, pill, powder, granule that the treatment coronary heart disease medicine group, which can make dosage form,.
Claims (4)
1. a kind of medicine group principle for treating coronary heart disease: cleaning heart aorta phlegm and toxin stasis.
2. a kind of coronary heart disease medicine group, including following component for the treatment of: 15 grams of dried rehamnnia root, 12 grams of ramulus cinnamomi, 9 grams of red ginseng, 10 grams of root of kirilow rhodiola,
It is 20 grams of ginkgo leaf, 12 grams of Rhizoma Chuanxiong, 15 grams of Radix Salviae Miltiorrhizae, 12 grams of rhizoma acori graminei, 10 grams of Radix Polygalae, 12 grams of Longstamen Onion Bulb, 15 grams of perillaseed, 9 grams of betel nut, male
15 grams of oyster, 10 grams of monkshood, 12 grams of cortex cinnamomi, 15 grams of rhizoma atractylodis, 9 grams of cimicifugae foetidae.
3. treatment coronary heart disease medicine group according to claim 2, which is characterized in that its core medicine group are as follows: 15 grams of Radix Salviae Miltiorrhizae, stone Chang
12 grams of Pu, 10 grams of Radix Polygalae, 12 grams of Longstamen Onion Bulb.
4. the production dosage form for the treatment of coronary heart disease medicine group according to claim 2: decoction, pill, powder, granule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811348766.3A CN109350685A (en) | 2018-11-13 | 2018-11-13 | A kind of the medicine group principle and its production dosage form of medicine group that treating coronary heart disease and treatment coronary heart disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811348766.3A CN109350685A (en) | 2018-11-13 | 2018-11-13 | A kind of the medicine group principle and its production dosage form of medicine group that treating coronary heart disease and treatment coronary heart disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109350685A true CN109350685A (en) | 2019-02-19 |
Family
ID=65344981
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811348766.3A Pending CN109350685A (en) | 2018-11-13 | 2018-11-13 | A kind of the medicine group principle and its production dosage form of medicine group that treating coronary heart disease and treatment coronary heart disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109350685A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1745795A (en) * | 2004-09-08 | 2006-03-15 | 湖南德海制药有限公司 | Medicine for preventing and treating coronary heart disease and preparation method thereof |
| CN106237069A (en) * | 2016-08-22 | 2016-12-21 | 唐海亮 | A kind of Chinese medicine formula treating coronary heart disease |
-
2018
- 2018-11-13 CN CN201811348766.3A patent/CN109350685A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1745795A (en) * | 2004-09-08 | 2006-03-15 | 湖南德海制药有限公司 | Medicine for preventing and treating coronary heart disease and preparation method thereof |
| CN106237069A (en) * | 2016-08-22 | 2016-12-21 | 唐海亮 | A kind of Chinese medicine formula treating coronary heart disease |
Non-Patent Citations (2)
| Title |
|---|
| 上海第一医学院华山医院: "《西医学习中医短期班讲义》", 30 September 1975 * |
| 郭冬梅: "中药方剂冠心十二味在稳定型心绞痛患者中的应用价值分析", 《现代中西医结合杂志》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101810827B (en) | Chinese medicinal preparation for treating mammary aggregation | |
| CN109529002A (en) | A kind of Chinese medicine composition and preparation method thereof for treating dumps emotional handicap type disease | |
| CN109350685A (en) | A kind of the medicine group principle and its production dosage form of medicine group that treating coronary heart disease and treatment coronary heart disease | |
| CN104524461A (en) | Medicine composition for treating myocarditis and application thereof | |
| CN104127827A (en) | Traditional Chinese medicine for treating biliary calculi | |
| CN105079438B (en) | A kind of pharmaceutical preparation for treating vital myocarditis | |
| CN104740579B (en) | Premenstrual peace piece and its preparation technology | |
| CN104547973A (en) | Health traditional Chinese medicine for treating chest obstruction and preparation method thereof | |
| CN102784376B (en) | Preparation method of traditional Chinese medicine for treating anorexia type acute glomerulonephritis | |
| CN115252700B (en) | Traditional Chinese medicine composition and medicine for treating cervical tinnitus and preparation method thereof | |
| CN103055159B (en) | Medicine for treating hypertension | |
| CN105902885A (en) | Traditional Chinese medicine for treatment of lung cancer | |
| CN109865050B (en) | Traditional Chinese medicine composition for inhibiting liver cancer and application thereof | |
| CN1121226C (en) | Chinese medicine for prepventing and treating iatrogenic hypercortisonism | |
| CN105770817A (en) | Qi-tonifying, blood-activating, dehumidifying and detoxifying different-skin-disease-treating traditional-Chinese-medicine composition formula | |
| CN107213293B (en) | Traditional Chinese medicine composition for treating chronic cerebral circulation insufficiency and preparation method thereof | |
| CN105664113A (en) | Traditional Chinese medicine for treating lung cancers | |
| CN104189539A (en) | Traditional Chinese medicine for treating allergic rhinitis | |
| CN104645224A (en) | Traditional Chinese medicine preparation for treating costal chondritis | |
| CN117122654A (en) | Traditional Chinese medicine prescription for treating thromboangiitis obliterans | |
| CN104740578B (en) | Premenstrual peace piece preparation technology and its detection method | |
| CN104208570A (en) | Traditional Chinese medicinal composition for treating heart failure, and preparation method thereof | |
| CN103341030B (en) | One treats leukemic Chinese medicine composition | |
| CN104367896A (en) | Pharmaceutical composition for treating qi deficiency and blood stasis-type apoplexy and preparation method thereof | |
| CN114288380A (en) | Traditional Chinese medicine composition for treating Crohn's disease and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190219 |